Coxsackievirus A6 U.K. Genetic and Clinical Epidemiology Pre- and Post-SARS-CoV-2 Emergence
Pathogens · 2024
DOI: 10.3390/pathogens13111020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Alice M Joyce und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, University of Nottingham, Nottingham NG7 2RD, UK. Hauptthemen laut MEDLINE: COVID-19, Hand, Foot and Mouth Disease, SARS-CoV-2, Phylogeny. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Clinical Virology Network, U.K. Clinical Virology Network.
Abstract (Originalsprache)
Coxsackievirus A6 (CVA6) has become increasingly clinically relevant as a cause of Hand, Foot and Mouth Disease (HFMD) globally since 2008. However, most laboratories do not routinely determine the enteroviral type of positive samples. The non-pharmaceutical measures introduced to curb transmission during the COVID-19 pandemic may also have perturbed CVA6 epidemiology. We thus aimed to determine the prevalence, clinical presentation and genetic relationship of CVA6 across three complete epidemic seasons: one pre-SARS-CoV-2 emergence and two post-SARS-CoV-2 emergence in our regional healthcare setting. Surplus diagnostic nucleic acid from diagnosed enteroviral positives diagnosed between September and December of 2018 and between May 2021 and April of 2023 was subject to VP1 gene sequencing to determine the CVA6 cases and interrogate their phylogenetic relationship. The confirmed CVA6 cases were also retrospectively clinically audited. CVA6 infections were identified in 33 and 69 individuals pre- and post-pandemic, respectively, with cases peaking in November of 2018 and 2022, but in October of 2021. HFMD was the primary diagnosis in 85.5% of the post-pandemic cases, but only 69.7% of the pre-pandemic cases, where respiratory and neurological symptoms (45.5% and 12.1%, respectively) were significantly elevated. A complete VP1 sequence was retrieved for 94% of the CVA6 cases, revealing that studied infections were genetically diverse and suggestive of multiple local and international transmission chains. CVA6 presented a significant clinical burden in our regional U.K. hospital setting both pre- and post-pandemic and was subject to dynamic clinical and genetic epidemiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Sciences, University of Nottingham, Nottingham NG7 2RD, UK.
- Wolfson Centre for Global Virus Research, University of Nottingham, Nottingham NG7 2UH, UK.
- The Pirbright Institute, Ash Road, Pirbright, Woking GU24 0NF, UK.
- Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.
- National Institute for Health Research Nottingham Biomedical Research Centre, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK.
- Clinical Microbiology, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK.
ORCID-Profile: Theocharis Tsoleridis, Alexander W Tarr, C Patrick McClure
Förderung
- Clinical Virology Network
- U.K. Clinical Virology Network
Zitieren
APA
Joyce, A. M., Hill, J. D., Tsoleridis, T., Astbury, S., Berry, L., Howson-Wells, H. C., Allen, N., Canning, B., Jones, C. B., Clark, G., Irving, W. L., Tarr, A. W., & McClure, C. P. (2024). Coxsackievirus A6 U.K. Genetic and Clinical Epidemiology Pre- and Post-SARS-CoV-2 Emergence. Pathogens. https://doi.org/10.3390/pathogens13111020
Vancouver
Joyce AM, Hill JD, Tsoleridis T, Astbury S, Berry L, Howson-Wells HC, et al. Coxsackievirus A6 U.K. Genetic and Clinical Epidemiology Pre- and Post-SARS-CoV-2 Emergence. Pathogens. 2024. doi:10.3390/pathogens13111020
BibTeX
@article{Joyce2024,
author = {Joyce, Alice M and Hill, Jack D and Tsoleridis, Theocharis and Astbury, Stuart and Berry, Louise and Howson-Wells, Hannah C and Allen, Nancy and Canning, Ben and Jones, Carl B and Clark, Gemma and Irving, William L and Tarr, Alexander W and McClure, C Patrick},
title = {Coxsackievirus A6 U.K. Genetic and Clinical Epidemiology Pre- and Post-SARS-CoV-2 Emergence},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13111020}
}
EUVIMED